Creo Medical Group plc provided revenue guidance for the year ended 31 December 2021. The company expects overall revenue for the year ended 31 December 2021 is expected to be just over £25 million - in line with the upgraded market expectations for 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.5 GBX | 0.00% | +3.55% | -20.65% |
May. 15 | Creo Medical on track to break even next year on strong 2023 results | AN |
May. 15 | Creo Medical Group PLC Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.65% | 162M | |
+75.69% | 12.57B | |
-25.33% | 7.34B | |
+9.30% | 6.61B | |
+18.48% | 5.39B | |
-16.21% | 4.84B | |
+17.14% | 4.53B | |
-22.63% | 3.91B | |
-23.21% | 2.91B | |
+57.56% | 2.37B |
- Stock Market
- Equities
- CREO Stock
- News Creo Medical Group PLC
- Creo Medical Group plc Provides Revenue Guidance for the Year Ended 31 December 2021